Fintel reports that on January 20, 2026, BTIG initiated coverage of Opus Genetics (NasdaqCM:IRD) with a Buy recommendation.
The average one-year price target for Opus Genetics (NasdaqCM:IRD) has been revised to $7.87 / share. This is an increase of 13.45% from the prior estimate of $6.94 dated November 7, 2025. The price ...
CPAs MUST EXERCISE CAUTION TO CAPTURE CORRECT income in respect of the decedent (IRD) deductions on clients’ returns. Since clients typically don’t understand the issue well enough to volunteer the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results